CHICAGO — Stereotactic body radiation therapy (SBRT) directed at progressive lesions in patients with oligoprogressive metastatic non-small cell lung cancer (NSCLC) was beneficial and significantly ...
Stereotactic body radiation therapy (SBRT) and surgery offer nearly equal overall survival rates for patients with stage I and II non–small­­ cell lung cancer (NSCLC), according to population-based ...
Due to breathing motion, lung tumours move during stereotactic body radiation therapy (SBRT). Scatter imaging, which collects photons scattered out of the radiation therapy beam, is a potential ...
Quality and Safety With Technological Advancements in Radiotherapy: An Overview and Journey Narrative From a Low- and Middle-Income Country Institution This study investigated a consecutive cohort of ...
SBRT versus surgery for early-stage NSCLC: A propensity-matched systematic review, meta-analysis, and meta-regression. This is an ASCO Meeting Abstract from the 2026 ASCO Annual Meeting I. This ...
Researchers from The University of Texas MD Anderson Cancer Center will present new data at the American Society for Radiation Oncology (ASTRO) 2025 Annual Meeting demonstrating that stereotactic body ...
SBRT and hypofractionated CRT showed similar effectiveness and low severe side effects in stage 1 NSCLC treatment. SBRT delivers higher radiation doses in fewer sessions, while hypofractionated CRT ...
Please provide your email address to receive an email when new articles are posted on . Patients with central lung tumors treated with single-fraction radiation did not experience any grade 3 or ...
Please provide your email address to receive an email when new articles are posted on . The number of facilities prescribing single-fraction lung SBRT is gradually growing, yet primarily at ...